Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.
Fatima M KhadadahSonia CerquozziHarold J OlneyChristina FragaJill DudeboutAnargyros XenocostasNicholas FinnVincent EthierM Lynn SavoieLambert BusqueKareem JamaniPhilip KuruvillaCarolyn FaughtBrian LeberRayan KaedbeySarit E AssoulineDennis KimPublished in: Leukemia research (2023)
This study confirmed clinical efficacy and tolerability of asciminib with real-world experience.